ArticleAntioxidants & redox signaling2007

Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Rajesh K Thimmulappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.